SCHEMBL4617285

SCHEMBL4617285

Cc1ccc(S(=O)(=O)c2ccccc2)cc1S(=O)(=O)NCCc1ccc(F)cc1

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SFRP1 Q8N474 2/20 0.84
TAAR1 Q96RJ0 1/20 0.62
ALDH1A1 P00352 6/20 0.53
TDP1 Q9NUW8 2/20 0.52
CA1 P00915 1/20 0.51
CA2 P00918 1/20 0.51
BRD4 O60885 1/20 0.51
BRD2 P25440 1/20 0.51
BRD3 Q15059 1/20 0.51
POLB P06746 2/20 0.50
CYP1A2 P05177 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C19 P33261 1/20 0.50
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
HTR2A P28223 1/20 0.48
HTR2C P28335 1/20 0.48
HTT P42858 2/20 0.47
NPSR1 Q6W5P4 1/20 0.47
PKM P14618 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6101465 0.96 SFRP1 (0.86) SFRP1TAAR1ALDH1A1TDP1BRD4
SCHEMBL4618887 0.95 SFRP1 (0.75) SFRP1TAAR1ALDH1A1TDP1BRD4
SCHEMBL4617746 0.92 SFRP1 (0.70) SFRP1TAAR1ALDH1A1TDP1POLB
SCHEMBL4619649 0.92 SFRP1 (0.70) SFRP1TAAR1ALDH1A1TDP1POLB
SCHEMBL4616099 0.92 SFRP1 (1.00) SFRP1TAAR1ALDH1A1TDP1CA1
SCHEMBL4618204 0.91 SFRP1 (0.88) SFRP1ALDH1A1TDP1CA1CA2
SCHEMBL4618849 0.90 SFRP1 (0.67) SFRP1TAAR1ALDH1A1TDP1POLB
SCHEMBL4616020 0.90 SFRP1 (0.67) SFRP1TAAR1ALDH1A1TDP1POLB
SCHEMBL6101322 0.90 SFRP1 (0.67) SFRP1TAAR1ALDH1A1TDP1BRD4
SCHEMBL6101732 0.90 SFRP1 (0.67) SFRP1TAAR1ALDH1A1TDP1CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101208299-A Diarylsulfone sulfonamides and use therof WYETH CORP (US) 2008-06-25 CN claimed
EP-1879859-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF Wyeth a Corporation of the State of Delaware (US) 2008-01-23 EP claimed
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US claimed
WO-2006124875-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF WYETH (US) 2006-11-23 WO claimed
CN-101208299-A Diarylsulfone sulfonamides and use therof WYETH CORP (US) 2008-06-25 CN disclosed
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof SFRP1, SOS1, FZD7 SFRP1 1/4885TAAR1 3692/4885ALDH1A1 1865/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.